Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.
Research output: Contribution to journal › Article
Atypical haemolytic uraemic syndrome (aHUS) is associated with dysfunction of the alternative pathway of complement. Disease activity subsides as renal failure progresses but recurs upon renal transplantation, indicating that viable renal tissue contributes to disease activity. We present evidence of cerebrovascular occlusive disease indicating that vascular injury may occur in the absence of kidneys.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Journal||Nephrology Dialysis Transplantation|
|Publication status||Published - 2013|
No data available